CoImmune, Inc.

Private

Durham, North CarolinaHealthcare & Life Scienceshttp://benecyte.com

Last Round

Series A

Nov 10, 2020

Total Funding Raised

$45M

Company Overview

CoImmune, Inc. is a biotechnology company that develops immuno-oncology therapies based on its proprietary allogeneic CAR-CIK and autologous RNA-loaded dendritic cell technology platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyimmuno-oncologyautologous cell therapydendritic cell vaccineCAR-CIKpersonalized medicinecancer immunotherapyclinical-stage biotechchimeric antigen receptorCAR-Thematologic malignanciessolid tumor treatmentbiopharmabiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoImmune, Inc. Comps

Public and private peers based on sector, stage, and business model.

CoImmune, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CoImmune, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 10, 2020

View all Funding Rounds

CoImmune, Inc. Investors

Notable investors and investment history

CoImmune, Inc. investors
Investor	Rounds
Korea Investment Partners	Series A
Brain Asset Management Co.,Ltd.	Series A

View all Investors

CoImmune, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CoImmune, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CoImmune, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina

Year Founded2019

Last FundingNov 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.